State Drug Firms Seek Diversification In India
This article was originally published in PharmAsia News
Executive Summary
State-run pharmaceutical companies in India seek to take advantage of their large land holdings to diversify into developing commercial complexes in information-technology parks they also run. Bengal Chemicals and Pharmaceuticals is building a large office complex on two acres it owns in Mumbai and plans to lease space while it pursues its drug-development business. Indian Drugs and Pharmaceuticals plans a similar arrangement at the four locations where it will include biotech parks. The state entities still need clearance from a group of government ministers before they can follow through with their diversification plans. (Click here for more